Suri Anish
- SEC CIK
- 0001739130
No open-market purchases or sales filed in the past year.
Current role at each company
- CUE Cue Biopharma, Inc.PRESIDENT AND CSOas of Jun 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Suri Anish as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2023 (view filing) | Aug 25 | 4 days | Suri AnishPRESIDENT AND CSO | PPurchase | +4.00K | $2.76 | +$11.0K | +3.0%135.6K after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Suri AnishPresident and CSO | SSale | −8.00K | $18.05 | −$144.4K | −7.8%94.0K after | |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Suri AnishPresident and CSO | SSale | −20.0K | $15.07 | −$301.4K | −17.5%94.0K after | |
| Sep 27, 2021 (view filing) | Sep 23 | 4 days | Suri AnishPRESIDENT AND CSO | SSale | −20.0K | $15.23 | −$304.6K | −21.1%74.8K after |